Join
Live feed
·
PRReleasevia Quantisnow
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

ByQuantisnow·Wall Street's wire, on your screen.
LBRX· LB Pharmaceuticals Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LBRX (LB Pharmaceuticals Inc) and more on Quantisnow.